Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

AstraZeneca PLC

+ Add to Watchlist

AZN:LN

4,691.000 GBp 70.500 1.48%

As of 12:35:04 ET on 03/26/2015.

Snapshot for AstraZeneca PLC (AZN)

Open: 4,724.500 Day's Range: 4,677.500 - 4,756.500 Volume: 2,923,386
Previous Close: 4,761.500 52wk Range: 3,718.500 - 4,870.000 1-Yr Rtn: +24.93%

Stock Chart for AZN

No chart data available.
  • AZN:LN 4,691.000
  • 1D
  • 1M
  • 1Y
4,761.500
Interactive AZN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AZN

Current P/E Ratio (ttm) 71.0495
Estimated P/E(12/2015) 16.4585
Relative P/E vs. UKX -
Earnings Per Share (USD) (ttm) 0.9800
Est. EPS (USD) (12/2015) 4.2240
Est. PEG Ratio -
Market Cap (M GBP) 59,260.86
Shares Outstanding (M) 1,263.29
30 Day Average Volume 2,662,940
Price/Book (mrq) 4.4822
Price/Sale (ttm) 3.3682
Dividend Indicated Gross Yield 4.19%
Cash Dividend (USD) 1.9000
Dividend Ex-Date 02/19/2015
5 Year Dividend Growth 4.49%
Next Earnings Announcement 04/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AZN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AZN

AstraZeneca PLC is a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia, and Infection.

Pascal SoriotChief Executive OfficerMarc DunoyerCFO/Executive Director
Shobie RamakrishnanChief Technology OfficerDavid SmoleyChief Information Officer
More Company Profile & Key Executives for AZN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil